Davis Select U.S. Equity ETF (DUSA) Sets New 12-Month Low at $21.84

Davis Select U.S. Equity ETF (NASDAQ:DUSA)’s share price hit a new 52-week low during trading on Tuesday . The company traded as low as $21.84 and last traded at $22.11, with a volume of 11225 shares traded. The stock had previously closed at $22.43.

Institutional investors have recently made changes to their positions in the stock. BB&T Securities LLC lifted its position in Davis Select U.S. Equity ETF by 74.6% during the second quarter. BB&T Securities LLC now owns 18,811 shares of the healthcare company’s stock worth $454,000 after buying an additional 8,037 shares in the last quarter. IFP Advisors Inc purchased a new stake in Davis Select U.S. Equity ETF in the second quarter valued at $537,000. Private Advisor Group LLC purchased a new stake in Davis Select U.S. Equity ETF in the third quarter valued at $560,000. Jane Street Group LLC purchased a new stake in Davis Select U.S. Equity ETF in the third quarter valued at $584,000. Finally, D.A. Davidson & CO. raised its position in Davis Select U.S. Equity ETF by 8.7% in the second quarter. D.A. Davidson & CO. now owns 45,375 shares of the healthcare company’s stock valued at $1,097,000 after purchasing an additional 3,635 shares during the period.

ILLEGAL ACTIVITY NOTICE: “Davis Select U.S. Equity ETF (DUSA) Sets New 12-Month Low at $21.84” was reported by WKRB News and is the sole property of of WKRB News. If you are viewing this piece on another domain, it was copied illegally and republished in violation of United States & international copyright & trademark law. The correct version of this piece can be accessed at https://www.wkrb13.com/2018/11/23/davis-select-u-s-equity-etf-dusa-sets-new-12-month-low-at-21-84.html.

About Davis Select U.S. Equity ETF (NASDAQ:DUSA)

DUSA Pharmaceuticals, Inc (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company’s marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp.

See Also: Hedge Funds

Receive News & Ratings for Davis Select U.S. Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davis Select U.S. Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply